5,6-dihydroxy-1-(2-imidazolinyl)tetralin has been researched along with Blood Pressure, High in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brondyk, H; Buckner, SA; Bush, EN; DeBernardis, JF; Kyncl, JJ | 1 |
1 other study(ies) available for 5,6-dihydroxy-1-(2-imidazolinyl)tetralin and Blood Pressure, High
| Article | Year |
|---|---|
Novel adrenergic compounds. I. Receptor interactions of ABBOTT-54741 [(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthtyl)imidazoline], an alpha-adrenergic agonist.
Topics: Adrenergic Agonists; Animals; Aorta; Dogs; Hemodynamics; Hypertension; Imidazoles; In Vitro Techniques; Male; Naphthalenes; Pulmonary Artery; Rabbits; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Saphenous Vein; Tetrahydronaphthalenes | 1989 |